June 26, 2018
PHILADELPHIA (Embargoed until 10 AM EDT, Tuesday, June 26, 2018) — Mark H. Crosthwaite, MEd, CNMT, PET, NMTCB(S), FSNMMI-TS, associate professor and program director of the baccalaureate nuclear medicine technology program, Department of Radiation Sciences, at Virginia Commonwealth University, Richmond, Virginia, has been named 2018-2019 president elect of the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS). The new slate of officers was introduced during the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2018 Annual Meeting, June 23–26 in Philadelphia, Pennsylvania.
“As SNMMI-TS president elect, my goal is to strengthen support of nuclear medicine technologists, ensuring they have the resources to advance their careers and to provide the highest quality of care to patients. There is always room to enhance communications, educational offerings, advocacy and research support. In the rapidly evolving field of nuclear medicine, I also firmly believe in sharing knowledge and working together with related societies and the international community to bring patients state-of-the-art imaging and precision therapies.”
Crosthwaite has four decades of experience as a nuclear medicine technologist (NMT). He has worked in his current position at Virginia Commonwealth University since 2005. Previously, he taught at Jefferson Community College and the University of Louisville in Kentucky. In Louisville, he also served as director of diagnostic imaging at Kindred Hospital and as an NMT with the Norton Healthcare System, Jewish Hospital and University of Louisville Hospital. Earlier in his career, Crosthwaite was program director of nuclear medicine technology at Wheeling College in Wheeling, West Virginia; chief technologist at St. Vincent Hospital in Erie, Pennsylvania; and NMT at the VA Medical Center in Butler, Pennsylvania.
Long active in SNMMI-TS, he has served in the National Council of Representatives and the House of Delegates at the national level. At the chapter level, Crosthwaite is currently in his second term as president of the Mid-Eastern Chapter and previously served as president of the Southeastern Chapter and the Pittsburgh Chapter. He has also held several positions on the Nuclear Medicine Technology Certification Board, including chair, treasurer and secretary. In addition, he assisted the Radiation Safety Branch in Kentucky with development of NMT state licensure.
Crosthwaite was named a Fellow of SNMMI-TS in June 2013. He has co-authored articles published in the Journal of Nuclear Medicine Technology and served as coordinating editor for NMT in-service reviews for Oakstone Medical Publishing. He has also presented lectures locally, regionally, nationally and internationally.
Crosthwaite has a bachelor’s degree in biological sciences from Drake University in Des Moines, Iowa; completed NMT training at Albert Einstein College Hospital in the Bronx, New York; and earned his master’s degree in education with an emphasis in occupational administration at the University of Louisville.
The new SNMMI leadership team announced at the Annual Meeting also includes Norman E. Bolus, MSPH, CNMT, FSNMMI-TS, Birmingham, Alabama, as the 2018-19 SNMMI-TS president. SNMMI officers elected for 2018-19 are Satoshi Minoshima, MD, PhD, Salt Lake City, Utah, as president; Vasken Dilsizian, MD, Baltimore, Maryland, as president-elect; and Alan B. Packard, PhD, Boston, Massachusetts, as vice president-elect.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.